Endoscopic Ultrasound-Guided Versus Percutaneous Transhepatic Biliary Drainage After Failed Endoscopic Retrograde Cholangiopancreatography in Malignant Biliary Obstruction: A Single-Center Retrospective Cohort
Authors:
- Wojciech CiesielskiWCWojciech Ciesielski
- Łukasz DurkoŁDŁukasz Durko
- Ludomir StefańczykLSLudomir Stefańczyk
- Adam DobekADAdam Dobek
- Anna BuliczABAnna Bulicz
- Amelia WojnickaAWAmelia Wojnicka
- Zuzanna SosnowskaZSZuzanna Sosnowska
- Agata GrochowskaAgata Grochowska
- Janusz StrzelczykJSJanusz Strzelczyk
- Piotr HogendorfPHPiotr Hogendorf
- Adam DurczyńskiADAdam Durczyński
- Tomasz KlimczakTKTomasz Klimczak
Open Access
Abstract
Background: After a failed endoscopic retrograde cholangiopancreatography (ERCP) for malignant biliary obstruction (MBO), second-line drainage is performed with endoscopic ultrasound-guided biliary drainage (EUS-BD) or percutaneous transhepatic biliary drainage (PTBD). We compared their effectiveness, safety, and short-term survival. Methods: We conducted a single-center retrospective cohort of 101 adults with MBO after they had experienced a failed ERCP (EUS-BD n = 37; PTBD n = 64). Allocation was non-randomized and driven by operational availability. Baseline laboratory tests (complete blood count, platelets, and C-reactive protein) and derived indices (neutrophil-to-lymphocyte ratio [NLR], platelet-to-lymphocyte ratio [PLR], lymphocyte-to-monocyte ratio [LMR], systemic immune-inflammation index [SII], systemic inflammation response index [SIRI], neutrophil-to-platelet score [NPS], and lymphocyte-to-CRP ratio [LCR]) were compared. Outcomes that were a technical success include: an early biochemical response (bilirubin reduction), complications (Clavien–Dindo), length of stay (LOS), and overall survival (OS). Between-group comparisons used the two-sided Mann–Whitney U test (continuous) and Fisher’s exact (binary) test. Survival was assessed by the Kaplan–Meier estimator using log-rank testing. To address later adoption of EUS-BD, we also estimated a restricted mean survival time of 180 days (RMST_0–180) with 95% confidence intervals (CIs). Results: Baseline inflammatory markers and composite indices were similar; baseline total bilirubin was higher in PTBD. The technical success was 100% in both groups. Early biochemical response was 86.5% after EUS-BD vs. 78.1% after PTBD (p = 0.43). Any complication occurred in 29.7% vs. 12.5% (p = 0.04); major complications (Clavien–Dindo ≥ III) occurred in 10.8% vs. 0% (p = 0.02), respectively; and the LOS did not differ (p = 0.21). OS favored EUS-BD (median 143 vs. 54 days and log-rank p = 0.012). RMST_0–180 was 111.1 days for EUS-BD vs. 71.4 days for PTBD (difference + 39.6 days; 95% CI 11.3–65.9). Conclusions: After a failed ERCP for MBO, EUS-BD and PTBD achieved universal technical success and similar early biochemical responses, but EUS-BD was associated with higher complication rates and a significantly longer six-month survival. These findings support the individualized selection balancing procedural risk with the anticipated survival benefit and highlight the need for prospective comparative studies.Keywords
This publication has 34 references indexed in Scilit:
- Clinical outcomes of percutaneous biliary drainage and quality of life assessment: a prospective observational studyAbdominal Radiology, 2025
- Endoscopic ultrasound-guided choledochoduodenostomy results in fewer complications than percutaneous drainage following failed ERCP in malignant distal biliary obstructionEndoscopy, 2025
- Inflammatory markers in predicting survival in pancreatic cancer: A Systematic review and Meta-AnalysisPancreatology, 2025
- American Society for Gastrointestinal Endoscopy guideline on the role of therapeutic EUS in the management of biliary tract disorders: summary and recommendationsGastrointestinal Endoscopy, 2024
- Endoscopic ultrasound- versus ERCP-guided primary drainage of inoperable malignant distal biliary obstruction: systematic review and meta-analysis of randomized controlled trialsEndoscopy, 2024
- Complications and management of interventional endoscopic ultrasound: A critical reviewBest Practice & Research Clinical Gastroenterology, 2024
- Therapeutic endoscopic ultrasound: European Society of Gastrointestinal Endoscopy (ESGE) GuidelineEndoscopy, 2021
- Prognostic significance of the systemic immune-inflammation index in pancreatic carcinoma patients: a meta-analysisBioscience Reports, 2021
- Neutrophil to lymphocyte ratio predicts prognosis in unresectable pancreatic cancerScientific Reports, 2020
- Procedures in Hepatogastroenterology1997